Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 21 Jul 2025

Role of homovanillic acid esters in the regulation of skin inflammatory pathways and their effect on tight junction protein expression

in Inflammation Pharmacology

Maria Fernanda Cervantes Recalde
Elena Zoe Bogensperger
Joachim Hans
Dominik Stuhlmann
Veronika Somoza
Barbara Lieder

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1629941

129 views

Clinical Trial

Accepted on 18 Jul 2025

The Anti-Inflammatory and Antioxidant Effects of Astaxanthin as an Adjunctive Therapy in Community-Acquired Pneumonia: A Randomized Controlled Trial

in Inflammation Pharmacology

Fatma Makram Youssef
Hayam Ateyya
Amir Eskander Hanna Samy
Eman Mohamed Elmokadem

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621308

179 views

Systematic Review

Accepted on 15 Jul 2025

Efficacy and Safety of Topical vs. Oral Calcium Channel Blockers for Chronic Anal Fissures: A Systematic Review and Meta-Analysis

in Inflammation Pharmacology

Li Tianshuo
Pengfei Ye
Xinli He
Chen Li
Lanlan Xi
Zuowu Xi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1642347

100 views

Correction

Published on 14 Jul 2025

Correction: Berberine ameliorates subarachnoid hemorrhage injury via induction of Sirtuin 1 and inhibiting HMGB1/Nf-κB pathway

in Inflammation Pharmacology

Xiang-Hua Zhang
Lei Peng
Jing Zhang
Yi-Peng Dong
Cheng-Jun Wang
Cang Liu
Da-Yong Xia
Xiang-Sheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540873

249 views

Original Research

Published on 11 Jul 2025

Lumefantrine ameliorates DSS-induced colitis by targeting FLI-1 to suppress NF-κB signaling

in Inflammation Pharmacology

Ji Yang
Peng Guo
Hongtao Luo
Xin Tang
Wei Liu
Xiaolin Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614978

393 views

Review

Accepted on 10 Jul 2025

Exploring Dupilumab for Asthma: From Mechanistic Insights to Clinical Outcomes, Safety and Cost-Effectiveness

in Inflammation Pharmacology

Omar Z Ameer
Ghaith K Mansour
Raghad S Al-Amoudi
Fahmi M Abu-Owaimer

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1631321

152 views

Original Research

Published on 07 Jul 2025

Antagonizing IL-6 receptor restores pancreatic tissue resident NK cells activation and ameliorates pancreatic injury in the mouse model of MASH

in Inflammation Pharmacology

Johnny Amer
Diana Abu Arra
Ahmad Salhab
Faris Kayed
Muneer Maali
Raghad Shweiki
Mustafa Ghanim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611637

629 views

Original Research

Accepted on 02 Jul 2025

Degradation of IRAK4 for the Treatment of Lipopolysaccharide induced acute lung injury in mice

in Inflammation Pharmacology

Bijun Ye
Shiyan Chen
Xiaohao Huang
Yinhong Qiu
Ruixiang Luo
Lulu Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609923

185 views

Original Research

Published on 02 Jul 2025

Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms

in Inflammation Pharmacology

Shuzhen Mao
Jiahui Huang
Junyan Li
Fang Sun
Qilian Zhang
Qing Cheng
Wei Zeng
Dongya Lei
Shiyan Wang
Jing Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551843

939 views

Systematic Review

Published on 01 Jul 2025

Immunomodulatory effects of ulinastatin combined with continuous blood purification in sepsis: a systematic review and meta-analysis

in Inflammation Pharmacology

Hui Gao
Zhiqiang Tang
Shucheng Zhao
Yuanjun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591470

735 views

Correction

Published on 01 Jul 2025

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations

in Inflammation Pharmacology

Lingli Wang
Fengsong Nie
Zhaoyu Lu
Yang Chong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1646006

579 views

Original Research

Accepted on 30 Jun 2025

Unique compound with anti-allergic action: inhibition of kinase activity of Lyn by KIRA6

in Inflammation Pharmacology

Goshi Matsushima
Yuri Matsui
Hanano Okamoto
Nagisa Umeda
Mai Kakimoto
Megumi Mino
Tadashi Nakagawa
Kaori Ishii
Yoshimi Matsuo
Daiki Matsubara

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625798

150 views

Original Research

Published on 27 Jun 2025

Protective effects of Salubrinal against H2O2-induced muscle wasting via eIF2α/ATF4 signaling pathway

in Inflammation Pharmacology

Siming Lin
Jingying Wu
Guili Lian
Weibin Wu
Weixiao Chen
Ai Chen
Li Luo
Liangdi Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607606

604 views

Review

Accepted on 25 Jun 2025

Research Progress in Treatment of Rheumatoid Arthritis with Sinomenine and Related Formulations Based on Different Administration Routes

in Inflammation Pharmacology

Wenya Wang
Zihui Wang
Aixia Ling
Chunyan Zhang
Mei Lv
Lufen Huang
Yanlian Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613679

217 views

Original Research

Published on 25 Jun 2025

Anti atherosclerosis effect and mechanism of a novel curcumin analogue CACN136: regulating macrophage M1/M2 polarization and lipid metabolism

in Inflammation Pharmacology

Qianjiao Zhao
Yueting Zhong
Zheng Li
Jia Tang
Chao Pi
Wenwu Zheng
Peng Shi
Ying Zuo
Jun Jiang
Yan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632647

744 views

Original Research

Published on 25 Jun 2025

Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study

in Inflammation Pharmacology

Xin Zhou
Rui Dong
Xiaoling Wei
Hao Ding
Xiaochen Wang
Wei Wu
Guiyun Kang
Lei Li
Xiang Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602637

636 views